The rapidly increasing prevalence of chronic diseases around the world is likely to fuel the demand for novel medications and better treatment options, propelling the worldwide market forward. Because of the increased desire for novel treatment options, there has been an increase in the use of drug intermediates as well as their use in research and clinical investigations.
Leading players in the biotechnology and pharmaceutical sectors along with research institutes are now increasingly focusing on R&D activities relating to drug creation and development. Future Market Insights (FMI) in a new study has forecast the global pharmaceutical intermediates to reach US$ 30 Bn in 2020, with the market predicted to exhibit a CAGR of 4% during the forecast period (2020-2030)
Sample of Research Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-4515
Pharmaceutical intermediates are used in during manufacturing of bulk drugs as raw materials. These are the material produced during the synthesis of an active pharmaceutical ingredient (API). However, pharmaceutical and biotech companies can make use of these drug intermediates for the purposes of research and development (R&D). Moreover, there are different forms of pharmaceutical intermediates available such as high quality pharmaceutical intermediates, moderate quality pharmaceutical intermediates and premium quality intermediates. The high-quality and premium pharmaceutical intermediates are mainly used for R&D activities.
Key Takeaways from Pharmaceutical Intermediates Marker Study
- The demand for chiral intermediates will continue rising through the forecast period
- East Asia will dominate in the global pharmaceutical intermediates market. China is expected to emerge as the most lucrative market for pharmaceutical intermediates in the region.
- Analgesics to remain primary application, expanding at Y-o-Y rate exceeding 6% through 2020
- The demand for Generic Drug Intermediates is expected to be higher than Branded Drug Intermediates
- Biotech and Pharma Companies will continue exhibiting high demand for pharmaceutical intermediates
Get In Touch With Our Team For 30% Flat Discount: https://www.futuremarketinsights.com/ask-question/rep-gb-4515
“Rising drug development activities worldwide as well as increasing adaption of pharmaceutical intermediates as raw material are driving the growth of global Pharmaceutical Intermediates market” says the FMI Analyst
Acquisitions, Partnerships and expansion are key Strategic Focus of Pharmaceutical Intermediates Market Players
Leading players in the Pharmaceutical Intermediates market on strengthening their market position though the Acquisition, Partnerships and expansion. For Instance,
- On April 2018, strategic collaboration between Porton Pharma Solutions, Ltd. And Codexis, Inc. to use Codexis’ biocatalyst technology within Porton’s global custom active pharmaceutical ingredients (API) and intermediate for manufacturing business.
- On June 2017, BASF SE is expanding its production capacity at Texas site, whereas it is also constructing new Ibuprofen API facility in Ludwigshafen, Germany, which is expected to be functional in 2021.
To receive an extensive list of important regions, ask for TOC here: https://www.futuremarketinsights.com/toc/rep-gb-4515
Key Participant Insights
The global market is set to expand its scope in the forecast period, due to rising prevalence of chronic disease globally and adoption of Pharmaceutical Intermediates at various stages of drug development by pharmaceutical manufacturers. In addition to this, cost effectiveness and rise in alternate methods for purification of oligonucleotide has augmented the sales of Pharmaceutical Intermediates.
The key market players covered by FMI include Chiracon GmbH, Aceto Corporation, Midas Pharma GmbH, Codexis, Lianhe Chemical Technology Co., Ltd, Sanofi S.A, Dishman Group And BASF SE, And Chemcon Speciality Chemicals Pvt. Ltd consolidating their positions through mergers, acquisitions and new product launches.
Need more information about Report Methodology: https://www.futuremarketinsights.com/askus/rep-gb-4515
Pharmaceutical Intermediates Market – Key Segments
Product
- Chemical Intermediates
- Bulk Drug Intermediates
- Chiral Intermediates
- Achiral Intermediates
- Custom Intermediates
Category
- Branded Drug Intermediates
- Generic Drug Intermediates
Application
- Analgesics
- Anti-inflammatory Drug
- Cardiovascular Drugs
- Anti-diabetic Drugs
- Antimicrobial Drugs
- Anti-cancer Drugs
- Others
End User
- Biotech and Pharma Companies
- Research Laboratory
- CMOs/CROs
Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Middle East and Africa (MEA)
- Oceania
Buy Now/Purchase: https://www.futuremarketinsights.com/checkout/4515
Have a Look at Related Research Reports of Healthcare Domain:
- https://adhipatialumni.com/blogs/63007/Self-Testing-Market-Size-Share-Application-Analysis-and-Growth-by
- https://writeablog.net/jaydip-fmi/self-testing-market-size-share-application-analysis-and-growth-by-forecast-to
- https://anotepad.com/notes/daktdf2m
- https://forecastanalysis.blogspot.com/2022/12/self-testing-market-size-share.html
- https://medium.com/@jaydip.fmi/insulin-pen-market-is-forecasted-to-surpass-us-46-9-bn-by-2031-4085decb0f3f
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8 years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs